143 related articles for article (PubMed ID: 14565159)
1. Antiangiogenic effects of dexamethasone in 9L gliosarcoma assessed by MRI cerebral blood volume maps.
Badruddoja MA; Krouwer HG; Rand SD; Rebro KJ; Pathak AP; Schmainda KM
Neuro Oncol; 2003 Oct; 5(4):235-43. PubMed ID: 14565159
[TBL] [Abstract][Full Text] [Related]
2. Functional and morphological effects of diazepam and midazolam on tumor vasculature in the 9L gliosarcoma brain tumor model using dynamic susceptibility contrast MRI: a comparative study.
Yan N; Zheng Y; Yang C
Drug Des Devel Ther; 2017; 11():2931-2936. PubMed ID: 29042753
[TBL] [Abstract][Full Text] [Related]
3. Dexamethasone normalizes brain tumor hemodynamics as indicated by dynamic susceptibility contrast MRI perfusion parameters.
Quarles CC; Krouwer HG; Rand SD; Schmainda KM
Technol Cancer Res Treat; 2005 Jun; 4(3):245-9. PubMed ID: 15896079
[TBL] [Abstract][Full Text] [Related]
4. Assessment of the morphological and functional effects of the anti-angiogenic agent SU11657 on 9L gliosarcoma vasculature using dynamic susceptibility contrast MRI.
Quarles CC; Schmainda KM
Magn Reson Med; 2007 Apr; 57(4):680-7. PubMed ID: 17390352
[TBL] [Abstract][Full Text] [Related]
5. Quantification of microvascular cerebral blood flux and late-stage tumor compartmentalization in 9L gliosarcoma using flow enhanced MRI.
Reynaud O; Geffroy F; Ciobanu L
NMR Biomed; 2013 Jun; 26(6):699-708. PubMed ID: 23335424
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of vascular endothelial growth factor (VEGF)-A causes a paradoxical increase in tumor blood flow and up-regulation of VEGF-D.
Moffat BA; Chen M; Kariaapper MS; Hamstra DA; Hall DE; Stojanovska J; Johnson TD; Blaivas M; Kumar M; Chenevert TL; Rehemtulla A; Ross BD
Clin Cancer Res; 2006 Mar; 12(5):1525-32. PubMed ID: 16533777
[TBL] [Abstract][Full Text] [Related]
7. Multimodality imaging of abnormal vascular perfusion and morphology in preclinical 9L gliosarcoma model.
Darpolor MM; Molthen RC; Schmainda KM
PLoS One; 2011 Jan; 6(1):e16621. PubMed ID: 21305001
[TBL] [Abstract][Full Text] [Related]
8. The effect of dexamethasone on the uptake of p-boronophenylalanine in the rat brain and intracranial 9L gliosarcoma.
Morris GM; Micca PL; Coderre JA
Appl Radiat Isot; 2004 Nov; 61(5):917-21. PubMed ID: 15308168
[TBL] [Abstract][Full Text] [Related]
9. Utility of simultaneously acquired gradient-echo and spin-echo cerebral blood volume and morphology maps in brain tumor patients.
Donahue KM; Krouwer HG; Rand SD; Pathak AP; Marszalkowski CS; Censky SC; Prost RW
Magn Reson Med; 2000 Jun; 43(6):845-53. PubMed ID: 10861879
[TBL] [Abstract][Full Text] [Related]
10. The Role of preload and leakage correction in gadolinium-based cerebral blood volume estimation determined by comparison with MION as a criterion standard.
Boxerman JL; Prah DE; Paulson ES; Machan JT; Bedekar D; Schmainda KM
AJNR Am J Neuroradiol; 2012 Jun; 33(6):1081-7. PubMed ID: 22322605
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the relationship between MR estimates of blood oxygen saturation and hypoxia: effect of an antiangiogenic treatment on a gliosarcoma model.
Lemasson B; Christen T; Serduc R; Maisin C; Bouchet A; Le Duc G; Rémy C; Barbier EL
Radiology; 2012 Dec; 265(3):743-52. PubMed ID: 22996750
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of cisplatin efficacy by thalidomide in a 9L rat gliosarcoma model.
Murphy S; Davey RA; Gu XQ; Haywood MC; McCann LA; Mather LE; Boyle FM
J Neurooncol; 2007 Nov; 85(2):181-9. PubMed ID: 17534579
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous assessment of vessel size index, relative blood volume, and vessel permeability in a mouse brain tumor model using a combined spin echo gradient echo echo-planar imaging sequence and viable tumor analysis.
Kording F; Weidensteiner C; Zwick S; Osterberg N; Weyerbrock A; Staszewski O; von Elverfeldt D; Reichardt W
J Magn Reson Imaging; 2014 Dec; 40(6):1310-8. PubMed ID: 24390982
[TBL] [Abstract][Full Text] [Related]
14. MR-derived cerebral blood volume maps: issues regarding histological validation and assessment of tumor angiogenesis.
Pathak AP; Schmainda KM; Ward BD; Linderman JR; Rebro KJ; Greene AS
Magn Reson Med; 2001 Oct; 46(4):735-47. PubMed ID: 11590650
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the 9L gliosarcoma implanted in the Fischer rat: an orthotopic model for a grade IV brain tumor.
Bouchet A; Bidart M; Miladi I; Le Clec'h C; Serduc R; Coutton C; Regnard P; Khalil E; Dufort S; Lemasson B; Laissue J; Pelletier L; Le Duc G
Tumour Biol; 2014 Jul; 35(7):6221-33. PubMed ID: 24633919
[TBL] [Abstract][Full Text] [Related]
16. Correlation of relative permeability and relative cerebral blood volume in high-grade cerebral neoplasms.
Provenzale JM; York G; Moya MG; Parks L; Choma M; Kealey S; Cole P; Serajuddin H
AJR Am J Roentgenol; 2006 Oct; 187(4):1036-42. PubMed ID: 16985154
[TBL] [Abstract][Full Text] [Related]
17. Continuous arterial spin labeling using a train of adiabatic inversion pulses.
Moffat BA; Chenevert TL; Hall DE; Rehemtulla A; Ross BD
J Magn Reson Imaging; 2005 Mar; 21(3):290-6. PubMed ID: 15723380
[TBL] [Abstract][Full Text] [Related]
18. A cyclooxygenase-2 (COX-2) inhibitor compared with dexamethasone in a survival study of rats with intracerebral 9L gliosarcomas.
Portnow J; Suleman S; Grossman SA; Eller S; Carson K
Neuro Oncol; 2002 Jan; 4(1):22-5. PubMed ID: 11772429
[TBL] [Abstract][Full Text] [Related]
19. Functional magnetic resonance (fMR) imaging of a rat brain tumor model: implications for evaluation of tumor microvasculature and therapeutic response.
Mazurchuk R; Zhou R; Straubinger RM; Chau RI; Grossman Z
Magn Reson Imaging; 1999 May; 17(4):537-48. PubMed ID: 10231180
[TBL] [Abstract][Full Text] [Related]
20. Endostatin reduces vascularization, blood flow, and growth in a rat gliosarcoma.
Sorensen DR; Read TA; Porwol T; Olsen BR; Timpl R; Sasaki T; Iversen PO; Benestad HB; Sim BK; Bjerkvig R
Neuro Oncol; 2002 Jan; 4(1):1-8. PubMed ID: 11772427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
